Tesaro (TSRO)

Add to Watchlists
Create an Alert
58.56 +0.56  +0.97% NASDAQ Aug 3, 17:01 Delayed 2m USD
View Full Chart
TSRO Price Chart
View All Events

TSRO Events

Date Type Description
08/06/2015 16:15 EDT Misc Tesaro Inc Second Quarter Earnings Results in 2015
08/06/2015 Earnings Tesaro Inc Second Quarter Earnings Results in 2015 Release
05/06/2015 Misc The Deutsche Bank 40th Annual Health Care Conference
05/05/2015 Misc The Mizuho Securities USA Third Annual Healthcare Corporate Access Day
05/05/2015 Misc The Citi Midwest Healthcare Access Day
04/30/2015 16:15 EDT Misc Tesaro Inc First Quarter Earnings Conference Call in 2015
04/30/2015 Earnings Tesaro Inc First Quarter Earnings in 2015 Release
02/19/2015 16:15 EST Misc Tesaro Inc Fourth Quarter Earnings Conference Call in 2014
02/19/2015 Earnings Tesaro Inc Fourth Quarter Earnings in 2014 Release
11/05/2014 16:15 EST Misc ESARO Inc. Third Quarter Financial Results Conference Call
View All Performance Charts

TSRO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Tesaro is up 103.6% over the last year vs S&P 500 Total Return up 10.90%, Opko Health up 84.69%, and Insys Therapeutics up 229.3%.

PDF Report for TSRO

Download TSRO Pro Report PDF
Advertisement

TSRO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.tesarobio.com
  • IR Website: http://ir.tesarobio.com/
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: September 30, 2015
  • Est. Current Fiscal Year End: December 31, 2015
  • Last Fiscal Quarter End: March 31, 2015
  • Last Fiscal Year End: December 31, 2014
  • Next Earnings Release: Aug. 6, 2015
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Tesaro Inc is an oncology-focused biopharmaceutical company engaged in improving the lives of cancer patients. The Company is developing three clinical-stage product candidates including rolapitant, niraparib and TSR-011.

TSRO Excel Add-In Codes

  • Name: =YCI("TSRO","name")
  • Description: =YCI("TSRO","description")
  • Sector: =YCI("TSRO","sector")
  • Industry: =YCI("TSRO","industry")
  • Est. Current Fiscal Year End: =YCI("TSRO","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.